procomvax
sanofi pasteur msd, snc - polyribosylribitol phosphate from haemophilus influenzae type b as prp-ompc, outer membrane protein complex of neisseria meningitidis (outer membrane protein complex of the b11 strain of neisseria meningitidis subgroup b), adsorbed hepatitis b surface antigen produced in recombinant yeast cells (saccharomyces cerevisiae) - hepatitis b; meningitis, haemophilus; immunization - vaccines - procomvax is indicated for vaccination against invasive disease caused by haemophilus influenzae type b and against infection caused by all known subtypes of hepatitis b virus in infants 6 weeks to 15 months of age.,
amvac metolachlor 960 ec herbicide
amvac australia pty ltd - metolachlor - emulsifiable concentrate - metolachlor anilide/aniline-acetanilides active 960.0 g/l - herbicide
amvac diquat 200 herbicide
amvac australia pty ltd - diquat as diquat dibromide monohydrate - soluble concentrate - diquat as diquat dibromide monohydrate pyridine-bipyridyl active 200.0 g/l - herbicide
amvac metalaxyl 50 fungicide
amvac australia pty ltd - metalaxyl - granular formulation - metalaxyl phenylamide active 50.0 g/kg - fungicide
amvac imidacloprid 600 flowable seed dressing insecticide
amvac australia pty ltd - imidacloprid - flowable concentrate for seed treatment - imidacloprid guanidine active 600.0 g/l - insecticide
amvac fluroxypyr 400 herbicide
amvac australia pty ltd - fluroxypyr as the methyl heptyl ester; n-methyl-2-pyrrolidone; liquid hydrocarbon (paraffin) - emulsifiable concentrate - fluroxypyr as the methyl heptyl ester pyridine-pyridinoxy active 400.0 g/l; n-methyl-2-pyrrolidone solvent other 46.0 g/l; liquid hydrocarbon (paraffin) solvent other 314.0 g/l - herbicide
micromaster kovac's reagents
imara microbiotech ltd, tanzania - kovac’s reagent -
simvacor 20
unipharm ltd, israel - simvastatin - film coated tablets - simvastatin 20 mg - simvastatin - simvastatin - coronary heart disease : in patients with coronary heart disease and hypercholesterolemia simvacor is indicated to: reduce the risk of total mortality by reducing coronary death reduce the risk of non-fatal myocardial infarction reduce the risk for undergoing myocardial revascularization procedures.reduce the risk of stroke and transient ischemic attacks (tia).hyperlipidemia: simvacor is indicated as an adjunct to diet to reduce elevated total-c ldl-c apo b and tg and to increase hdl-c in patients with primary hypercholesterolemia( heterozygous familial and nonfamilial) and mixed dyslipidemia (frederickson types iia and iib) simvacor therefore lowers the ldl-c/hdl-c and the total-c/hdl-c ratios.homozygous familial hypercholesterolemia: simvacor is also indicated as an adjunct to diet and other non-dietary measures in reducing elevated total cholesterol ldl-cholesterol and apolipoprotein b in patients with homozygous familial hypercholesterolemia when response to these measures is inadequate. hypertrigly
simvacor 10
unipharm ltd, israel - simvastatin - film coated tablets - simvastatin 10 mg - simvastatin - simvastatin - coronary heart disease : in patients with coronary heart disease and hypercholesterolemia simvacor is indicated to: reduce the risk of total mortality by reducing coronary death reduce the risk of non-fatal myocardial infarction reduce the risk for undergoing myocardial revascularization procedures. reduce the risk of stroke and transient ischemic attacks (tia). hyperlipidemia: simvacor is indicated as an adjunct to diet to reduce elevated total-c ldl-c apo b and tg and to increase hdl-c in patients with primary hypercholesterolemia( heterozygous familial and nonfamilial) and mixed dyslipidemia (frederickson types iia and iib) simvacor therefore lowers the ldl-c/hdl-c and the total-c/hdl-c ratios. homozygous familial hypercholesterolemia: simvacor is also indicated as an adjunct to diet and other non-dietary measures in reducing elevated total cholesterol ldl-cholesterol and apolipoprotein b in patients with homozygous familial hypercholesterolemia when response to these measures is inadequate. hypertri
simvacor 40
unipharm ltd, israel - simvastatin - film coated tablets - simvastatin 40 mg - simvastatin - simvastatin - coronary heart disease : in patients with coronary heart disease and hypercholesterolemia simvacor is indicated to: reduce the risk of total mortality by reducing coronary death reduce the risk of non-fatal myocardial infarction reduce the risk for undergoing myocardial revascularization procedures. reduce the risk of stroke and transient ischemic attacks (tia). hyperlipidemia: simvacor is indicated as an adjunct to diet to reduce elevated total-c ldl-c apo b and tg and to increase hdl-c in patients with primary hypercholesterolemia( heterozygous familial and nonfamilial) and mixed dyslipidemia (frederickson types iia and iib) simvacor therefore lowers the ldl-c/hdl-c and the total-c/hdl-c ratios.homozygous familial hypercholesterolemia: simvacor is also indicated as an adjunct to diet and other non-dietary measures in reducing elevated total cholesterol ldl-cholesterol and apolipoprotein b in patients with homozygous familial hypercholesterolemia when response to these measures is inadequate. hypertrig